Walgreens to Participate in TD Cowen's 9th Annual FutureHealth Conference

Business Wire 3-Sep-2024 9:00 AM

Walgreens today announced that Ramita Tandon, Chief Clinical Trials Officer, will deliver a keynote presentation at TD Cowen's 9th Annual FutureHealth Conference, Tuesday, Sept. 10 at 4:10 p.m. EST.

An audio portion of the presentation will be webcast live and can be accessed through the Walgreens Boots Alliance investor relations website at https://investor.walgreensbootsalliance.com/press-releases/events-and-presentations.

About Walgreens Walgreens (www.walgreens.com) is included in the U.S. Retail Pharmacy and U.S. Healthcare segments of Walgreens Boots Alliance, Inc. (NASDAQ:WBA), an integrated healthcare, pharmacy and retail leader. True to its purpose of "more joyful lives through better health," Walgreens has a more than 120-year heritage of caring for communities and providing trusted pharmacy services, and today is playing a greater role as an independent partner of choice offering healthcare services that improve care, lower costs, and help patients. Operating nearly 9,000 retail locations across the U.S. and Puerto Rico, Walgreens is proud to serve nearly 9 million customers and patients daily. The company's pharmacists are playing a more critical role in healthcare than ever before, providing a wide range of pharmacy and healthcare services, including those that drive equitable access to care for some of the nation's most underserved populations. Walgreens offers customers and patients a true omnichannel experience, with fully integrated physical and digital platforms designed to deliver high-quality products and healthcare services. Within the U.S. Healthcare segment, Walgreens portfolio also includes businesses in primary care, multi-specialty, post-acute care, urgent care, specialty pharmacy services, population health and provider enablement.

More Company information is available at www.walgreensbootsalliance.com.

(WBA-GEN)

View source version on businesswire.com: https://www.businesswire.com/news/home/20240903161787/en/